A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

Clinical trial NCT01865747 · COMPLETED

Trial details

NCT number: NCT01865747
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2013-06-01
Primary completion: 2015-05-22
Enrollment: 658

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.